Porównanie trendów obciążenia idiopatyczną epilepsją w Chinach i na świecie na podstawie Globalnego Studium Obciążenia Chorobami z 2021 roku
Comparative trends in idiopathic epilepsy burden in China and worldwide based on Global Burden of Disease Study 2021
W skrócie
Badanie analizuje zmiany liczby zachorowań, rozpowszechnienia, śmiertelności i niepełnosprawności spowodowanej idiopatyczną epilepsją (epilepsją bez identyfikowalnej przyczyny) w Chinach i na całym świecie od 1990 do 2021 roku. Wyniki pokazują, że chociaż liczba nowych przypadków i pacjentów z epilepsją rośnie, to ciężkość choroby i liczba zgonów znacznie się zmniejszają, szczególnie w Chinach. Prognoza na kolejne 20 lat wskazuje, że trend ten będzie się utrzymywać, co sugeruje poprawę zdrowotną dzięki zmianom w systemie opieki zdrowotnej i profilaktyce.
Oryginalny abstract (angielski)
BACKGROUND: Idiopathic epilepsy, defined by the absence of identifiable structural or metabolic etiologies, remains a significant contributor to the global neurological disease burden. However, long-term comparisons between China and the global level are limited. This study analyzed and compared trends in incidence, prevalence, mortality, and disability-adjusted life years (DALYs) of idiopathic epilepsy between China and the global level from 1990 to 2021, and included predictive analysis of future trends. METHODS: The key metrics including incidence, prevalence, mortality, and DALYs, along with their corresponding age-standardized rates, were extracted and analyzed. Joinpoint regression was employed to assess temporal trends, Bayesian age-period-cohort models were used for future projections, and decomposition analysis quantified the contributions of population growth, population aging, and epidemiological changes. RESULTS: From 1990 to 2021, both China and the world showed increasing trends in incidence and prevalence. In contrast, DALYs and mortality decreased significantly, with China showing a more pronounced decline (AAPC: -1.790%; -2.649%) than the global level (AAPC: -0.525%; -0.535%). Decomposition analysis revealed that epidemiologic changes played a greater role in China's DALY and mortality reductions. Projection analysis suggested continued increases in incidence and prevalence, but ongoing declines in DALYs and mortality by 2045, especially in China. DISCUSSION: The burden of idiopathic epilepsy has evolved differently in China compared with global trends, with China experiencing a more substantial reduction in disease severity and mortality. These findings highlight the need for targeted prevention strategies and health system enhancements tailored to specific demographic and epidemiological profiles.